Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Radiotherapy × Clear all

Phase

Phase 3 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 35 Prostatic Neoplasms 25 Lymphoma 12 Carcinoma, Non-Small-Cell Lung 12 Head and Neck Neoplasms 11 Recurrence 10 Rectal Neoplasms 10 Neoplasms 9 Lung Neoplasms 9 Uterine Cervical Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasm Metastasis 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 7 Central Nervous System Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Multiple Myeloma 6 Hyperthermia 6 Carcinoma, Intraductal, Noninfiltrating 6 Carcinoma, Hepatocellular 6 Brain Neoplasms 6 Lymphoma, Follicular 5 Hodgkin Disease 5 Glioblastoma 5 Dendritic Cell Sarcoma, Interdigitating 5 Congenital Abnormalities 5 Burkitt Lymphoma 5

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Hypoxia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡